Debra Ritzwoller to Humans
This is a "connection" page, showing publications Debra Ritzwoller has written about Humans.
Connection Strength
2.222
-
Development of an Electronic Health Record-Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium. JCO Clin Cancer Inform. 2023 Sep; 7:e2300063.
Score: 0.063
-
Individuals Eligible for Lung Cancer Screening Less Likely to Receive Screening When Enrolled in Health Plans With Deductibles. Med Care. 2023 Oct 01; 61(10):665-673.
Score: 0.063
-
The Pathways to Prevention program: nutrition as prevention for improved cancer outcomes. J Natl Cancer Inst. 2023 08 08; 115(8):886-895.
Score: 0.063
-
Smoking status and the association between patient-level factors and survival among lung cancer patients. J Natl Cancer Inst. 2023 08 08; 115(8):937-948.
Score: 0.063
-
Uptake of novel systemic therapy: Real world patterns among adults with advanced non-small cell lung cancer. Cancer Treat Res Commun. 2023; 36:100730.
Score: 0.062
-
Patient Factors Associated With Use of Adult Primary Care and Virtual Visits During the COVID-19 Pandemic. Med Care. 2023 04 01; 61(Suppl 1):S12-S20.
Score: 0.061
-
Management of Neck or Back Pain in Ambulatory Care: Did Visit Mode or the COVID-19 Pandemic Affect Provider Practice or Patient Adherence? Med Care. 2023 04 01; 61(Suppl 1):S30-S38.
Score: 0.061
-
Did Access to Ambulatory Care Moderate the Associations Between Visit Mode and Ancillary Services Utilization Across the COVID-19 Pandemic Period? Med Care. 2023 04 01; 61(Suppl 1):S39-S46.
Score: 0.061
-
Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening. J Thorac Oncol. 2022 12; 17(12):1355-1364.
Score: 0.059
-
Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions. J Natl Cancer Inst Monogr. 2022 Jul 05; 2022(59):42-50.
Score: 0.058
-
A Feasible Path to Reductions in Racial and Ethnic Disparities in Lung Cancer Screening? JNCI Cancer Spectr. 2022 May 02; 6(3).
Score: 0.057
-
Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. JAMA Netw Open. 2021 10 01; 4(10):e2128176.
Score: 0.055
-
Regarding the Utility of Unstructured Data and Natural Language Processing for Identification of Breast Cancer Recurrence. JCO Clin Cancer Inform. 2021 09; 5:1024-1025.
Score: 0.055
-
Real-world Clinical Implementation of Lung Cancer Screening-Evaluating Processes to Improve Screening Guidelines-Concordance. J Gen Intern Med. 2020 04; 35(4):1143-1152.
Score: 0.049
-
Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium. Cancer Prev Res (Phila). 2020 02; 13(2):129-136.
Score: 0.049
-
Long-Term Patterns of Oral Anticancer Agent Adoption, Duration, and Switching in Patients With CML. J Natl Compr Canc Netw. 2019 10 01; 17(10):1166-1172.
Score: 0.048
-
Melanoma incidence, recurrence, and mortality in an integrated healthcare system: A retrospective cohort study. Cancer Med. 2019 08; 8(9):4508-4516.
Score: 0.047
-
Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease. J Oncol Pract. 2019 07; 15(7):e616-e627.
Score: 0.047
-
Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis. Health Serv Res. 2018 12; 53(6):5106-5128.
Score: 0.044
-
Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm. J Natl Cancer Inst. 2018 03 01; 110(3):273-281.
Score: 0.043
-
Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2017 12; 55(12):e88-e98.
Score: 0.042
-
Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol. 2017 08; 49:186-194.
Score: 0.041
-
Effect of Angiotensin System Inhibitors on Survival in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2017 03; 18(2):189-197.e3.
Score: 0.039
-
Use of Bevacizumab in Community Settings: Toxicity Profile and Risk of Hospitalization in Patients With Advanced Non-Small-Cell Lung Cancer. J Oncol Pract. 2015 Sep; 11(5):356-62.
Score: 0.036
-
Advanced imaging among health maintenance organization enrollees with cancer. J Oncol Pract. 2014 Jul; 10(4):231-8.
Score: 0.033
-
Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience. J Thorac Oncol. 2014 May; 9(5):692-701.
Score: 0.033
-
Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013 Oct; 51(10):e67-73.
Score: 0.032
-
Economic analyses of the Be Fit Be Well program: a weight loss program for community health centers. J Gen Intern Med. 2013 Dec; 28(12):1581-8.
Score: 0.031
-
Patterns and predictors of first-line chemotherapy use among adults with advanced non-small cell lung cancer in the cancer research network. Lung Cancer. 2012 Dec; 78(3):245-52.
Score: 0.030
-
Twelve-month outcomes of an Internet-based diabetes self-management support program. Patient Educ Couns. 2012 Apr; 87(1):81-92.
Score: 0.027
-
Outcomes of minimal and moderate support versions of an internet-based diabetes self-management support program. J Gen Intern Med. 2010 Dec; 25(12):1315-22.
Score: 0.026
-
Viva bien!: Overcoming recruitment challenges in a multiple-risk-factor diabetes trial. Am J Health Behav. 2010 Jul-Aug; 34(4):432-41.
Score: 0.025
-
Recruitment to a randomized web-based nutritional intervention trial: characteristics of participants compared to non-participants. J Med Internet Res. 2009 Aug 26; 11(3):e38.
Score: 0.024
-
Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting. Curr Med Res Opin. 2009 Jun; 25(6):1319-28.
Score: 0.023
-
Costing behavioral interventions: a practical guide to enhance translation. Ann Behav Med. 2009 Apr; 37(2):218-27.
Score: 0.023
-
The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord. 2006 Sep 18; 7:72.
Score: 0.019
-
Economic analysis of the Mediterranean Lifestyle Program for postmenopausal women with diabetes. Diabetes Educ. 2006 Sep-Oct; 32(5):761-9.
Score: 0.019
-
Comparison of syndromic surveillance and a sentinel provider system in detecting an influenza outbreak--Denver, Colorado, 2003. MMWR Suppl. 2005 Aug 26; 54:151-6.
Score: 0.018
-
Effectiveness of the 2003-2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics. 2005 Jul; 116(1):153-9.
Score: 0.018
-
Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med. 2005 Mar; 7(3):191-7.
Score: 0.017
-
Creating standard cost measures across integrated health care delivery systems. J Natl Cancer Inst Monogr. 2005; (35):80-7.
Score: 0.017
-
Implementation of a Secure Firearm Storage Program in Pediatric Primary Care: A Cluster Randomized Trial. JAMA Pediatr. 2024 Nov 01; 178(11):1104-1113.
Score: 0.017
-
Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study. Ann Intern Med. 2024 Jan; 177(1):18-28.
Score: 0.016
-
Syndromic surveillance using minimum transfer of identifiable data: the example of the National Bioterrorism Syndromic Surveillance Demonstration Program. J Urban Health. 2003 Jun; 80(2 Suppl 1):i25-31.
Score: 0.015
-
Impact of COVID-19 on Trends in Outpatient Clinic Utilization: A Tale of 2 Departments. Med Care. 2023 04 01; 61(Suppl 1):S4-S11.
Score: 0.015
-
Virtual Care and Urinary Tract Infection Management: Comparing Ancillary Service Orders and Patient Order Fulfillments Between Virtual and In-person Encounters During the COVID-19 Pandemic in the United States. Med Care. 2023 04 01; 61(Suppl 1):S21-S29.
Score: 0.015
-
Health-care-Related Practices in Virtual Behavioral Health Treatment for Major Depression Before and During the COVID-19 Pandemic. Med Care. 2023 04 01; 61(Suppl 1):S47-S53.
Score: 0.015
-
Development of a Common Data Model for a Multisite and Multiyear Study of Virtual Visit Implementation: A Case Study. Med Care. 2023 04 01; 61(Suppl 1):S54-S61.
Score: 0.015
-
Equitable implementation of S.A.F.E. Firearm: A multi-method pilot study. Prev Med. 2022 12; 165(Pt A):107281.
Score: 0.015
-
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
Score: 0.015
-
Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1521-1531.
Score: 0.015
-
Cancer Survivorship and Supportive Care Economics Research: Current Challenges and Next Steps. J Natl Cancer Inst Monogr. 2022 Jul 05; 2022(59):57-63.
Score: 0.015
-
Study protocol for a type III hybrid effectiveness-implementation trial of strategies to implement firearm safety promotion as a universal suicide prevention strategy in pediatric primary care. Implement Sci. 2021 09 22; 16(1):89.
Score: 0.014
-
Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond. Prev Med. 2021 10; 151:106595.
Score: 0.014
-
Can digital communication technology reduce health system personnel time? An evaluation of personnel requirements and costs in a randomized controlled trial. Transl Behav Med. 2021 04 07; 11(3):863-869.
Score: 0.013
-
Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2021 03; 160(4):999-1002.
Score: 0.013
-
Adults With Asthma Experience No Increase in Asthma-related Exacerbations When Digital Communication Technology Tools Are Employed to Offset Provider Workload: A Pragmatic Randomized Trial. Med Care. 2020 04; 58(4):352-359.
Score: 0.012
-
Planning for Implementation Success Using RE-AIM and CFIR Frameworks: A Qualitative Study. Front Public Health. 2020; 8:59.
Score: 0.012
-
A Quasi-Experimental Analysis of Lethal Means Assessment and Risk for Subsequent Suicide Attempts and Deaths. J Gen Intern Med. 2020 06; 35(6):1709-1714.
Score: 0.012
-
Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders. Gen Hosp Psychiatry. 2020 Jan - Feb; 62:21-27.
Score: 0.012
-
Changes in use of opioid therapy after colon cancer diagnosis: a population-based study. Cancer Causes Control. 2019 Dec; 30(12):1341-1350.
Score: 0.012
-
Advancing Symptom Alleviation with Palliative Treatment (ADAPT) trial to improve quality of life: a study protocol for a randomized clinical trial. Trials. 2019 Jun 13; 20(1):355.
Score: 0.012
-
Risk of colon cancer recurrence in relation to diabetes. Cancer Causes Control. 2018 Nov; 29(11):1093-1103.
Score: 0.011
-
Stakeholder perspectives on costs and resource expenditures: tools for addressing economic issues most relevant to patients, providers, and clinics. Transl Behav Med. 2018 09 08; 8(5):675-682.
Score: 0.011
-
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep; 119:70-78.
Score: 0.011
-
Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
Score: 0.011
-
Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System. J Oncol Pract. 2017 05; 13(5):e441-e450.
Score: 0.010
-
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
Score: 0.010
-
The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 11; 27(11):1315-1323.
Score: 0.010
-
Effectiveness and cost of influenza vaccine reminders for adults with asthma or chronic obstructive pulmonary disease. Am J Manag Care. 2015 Jul 01; 21(7):e405-13.
Score: 0.009
-
Adoption, reach, implementation, and maintenance of a behavioral and mental health assessment in primary care. Ann Fam Med. 2014 Nov-Dec; 12(6):525-33.
Score: 0.009
-
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care. 2014 Oct; 52(10):e65-73.
Score: 0.008
-
Preventive care receipt and office visit use among breast and colorectal cancer survivors relative to age- and gender-matched cancer-free controls. J Cancer Surviv. 2015 Jun; 9(2):201-7.
Score: 0.008
-
Positron emission tomography and stage migration in head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2014 Jul; 140(7):654-61.
Score: 0.008
-
The influence of deductible health plans on receipt of the human papillomavirus vaccine series. J Adolesc Health. 2014 Mar; 54(3):275-81.
Score: 0.008
-
Designing a valid randomized pragmatic primary care implementation trial: the my own health report (MOHR) project. Implement Sci. 2013 Jun 25; 8:73.
Score: 0.008
-
When does an episode of care for cancer begin? Med Care. 2013 Apr; 51(4):324-9.
Score: 0.008
-
The challenge of conducting comparative effectiveness research in cancer: the impact of a fragmented U.S. health-care system. J Natl Cancer Inst Monogr. 2013; 2013(46):99-105.
Score: 0.008
-
A standardized relative resource cost model for medical care: application to cancer control programs. J Natl Cancer Inst Monogr. 2013; 2013(46):106-16.
Score: 0.008
-
Comparing cancer care, outcomes, and costs across health systems: charting the course. J Natl Cancer Inst Monogr. 2013; 2013(46):124-30.
Score: 0.008
-
Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intent. Cancer. 2012 Nov 15; 118(22):5644-51.
Score: 0.007
-
Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med. 2012 Apr 09; 172(7):565-74.
Score: 0.007
-
Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer. Oncologist. 2012; 17(3):419-27.
Score: 0.007
-
Identifying and oversampling Hispanics by the Passel-Word surname list for enrollment in a web-based nutritional intervention. Ethn Dis. 2010; 20(1):15-21.
Score: 0.006
-
Accuracy and complexities of using automated clinical data for capturing chemotherapy administrations: implications for future research. Med Care. 2009 Oct; 47(10):1091-7.
Score: 0.006
-
Long-term results of a smoking reduction program. Med Care. 2009 Jan; 47(1):115-20.
Score: 0.006
-
Using theory and technology to design a practical and generalizable smoking reduction intervention. Health Promot Pract. 2010 Sep; 11(5):675-84.
Score: 0.006
-
Reach, engagement, and retention in an Internet-based weight loss program in a multi-site randomized controlled trial. J Med Internet Res. 2007 May 09; 9(2):e11.
Score: 0.005
-
Assessing controversial direct-to-consumer advertising for hereditary breast cancer testing: reactions from women and their physicians in a managed care organization. Am J Manag Care. 2005 Oct; 11(10):601-8.
Score: 0.005
-
Simulated anthrax attacks and syndromic surveillance. Emerg Infect Dis. 2005 Sep; 11(9):1394-8.
Score: 0.005
-
Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med. 2005 Aug; 29(2):77-84.
Score: 0.004
-
Practical clinical trials for translating research to practice: design and measurement recommendations. Med Care. 2005 Jun; 43(6):551-7.
Score: 0.004
-
National Bioterrorism Syndromic Surveillance Demonstration Program. MMWR Suppl. 2004 Sep 24; 53:43-9.
Score: 0.004
-
Tobacco control efforts in managed care: what do the doctors think? Am J Manag Care. 2004 Mar; 10(3):193-8.
Score: 0.004
-
Does payment drive procedures? Payment for specialty services and procedure rate variations in 3 HMOs. Am J Manag Care. 2004 Mar; 10(3):229-37.
Score: 0.004
-
Extending health maintenance organization insurance to the uninsured. A controlled measure of health care utilization. JAMA. 1997 Apr 02; 277(13):1067-72.
Score: 0.003